Loading...
Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid Cancer
Weight loss is one of the most frequent adverse events during treatment with multikinase inhibitors, but scanty data are available on its extent and characteristics. This is the first assessment of the body composition by bioelectrical impedance analysis and of circulating leptin and ghrelin levels,...
Na minha lista:
| Udgivet i: | Eur Thyroid J |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7024882/ https://ncbi.nlm.nih.gov/pubmed/32071896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504048 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|